Advertisement

POZ October-November 2011

POZ October-November 2011

In every issue, you'll find the hottest topics of interest to our readers along with cutting-edge health information.

Features

POZ Magazine

R.I.P. HIV

Thirty years after people first started dying from a then-unknown virus, we face a thrilling tipping point in AIDS history. Leading scientis...

From the Editor

POZ Magazine

Retiring the Ribbon

The end of AIDS. Doesn't that have a wonderful ring to it?

Feedback

POZ Magazine

Letters- October/November 2011

Girl PowerIn “Sisters Act” (July/August 2011), three African-American New Jersey women&#

The POZ Q+A

POZ Magazine

High-Impact Prevention

Kevin Fenton explains a new approach to prevent HIV in the communities most at risk.

What You Need to Know

POZ Magazine

Health Care Should Be a Human Right—for All

Two changes to health care (one actual and one proposed) could make it easier for Americans to access lifesaving tools when they're needed.

POZ Magazine

Too Few Pharma Companies in the Patent Pool

Earlier this year, Gilead Sciences became the first manufacturer of HIV meds to join the Medicines Patent Pool Foundation.

POZ Magazine

Legislation Proposed to End Criminal HIV Laws

HIV-positive individuals are often presumed guilty and must prove themselves otherwise when it comes to laws that criminalize HIV, but that ma...

POZ Magazine

AIDS Is Not an "Automatic Death Sentence"

The law has finally started to catch up with the science—in Canada, at least. 

POZ Magazine

Geckos Don't Cure AIDS

Officials in the Philippines are fighting a growing trend of using geckos (small lizards) to treat AIDS.

We Hear You

POZ Magazine

The PrEP Debate

Pre-exposure prophylaxis, or PrEP, is the practice of people at risk for HIV taking daily doses of antiretroviral medication (ARVs) to reduce...

What Matters to You

POZ Magazine

Getting HIV Care Without Getting Deported

Treatment options and help are available for people with HIV—and without immigration papers.

Treatment News

POZ Magazine

A Peek Into the Pipeline

A new entry inhibitor (EI) is in the works. 

POZ Magazine

Savvy Survival Strategy

Researchers with the University of North Carolina at Chapel Hill have found that just being in an HIV clinical trial can enhance your health.&...

POZ Magazine

Going Norvir-Free?

To work most effectively, protease inhibitors (PIs) have long relied on a boost from Norvir (ritonavir). 

POZ Magazine

Cure Watch

Recent advances in AIDS research have increased the hope of finding a functional, or therapeutic, cure for HIV.

POZ Magazine

Listen Up

Hearing loss in people with HIV results from age, race and other risk factors, not the virus.

POZ Magazine

Oh Baby!

At a U.N. summit this past June, the Elizabeth Glaser Pediatric AIDS Foundation announced its "Global Plan Towards the Elimination of New HIV...

POZ Magazine

Make Some Bones About It

A study by the Department of Veterans Affairs (VA) found that, while some HIV meds can play a role in the disproportionately high incidence of...

Comfort Zone

POZ Magazine

Waiting to Inhale

Every day, all day, in and out. It's so natural, you do it in your sleep. 

POZ Heroes

POZ Magazine

Defying Gravity

Orbit Clanton, co-founder of Perceptions for People with Disabilities, was diagnosed with GRID in 1982. (Watch video.)

Advertisement

Hot topics